Shipping delays may occur due to increased holiday volume. Please order early or upgrade shipping for timely delivery.
Header

FDA Issues New Draft Guidance That Threatens Veterinary Medicine

Developed in collaboration with
Last reviewed: 12/18/2019

FDA’s Center for Veterinary Medicine (CVM) recently issued draft guidance (GFI #256) that, if finalized, threatens to have serious and damaging ramifications for your practice and your patients.

How will this affect your practice and patients?

If finalized,

  • Your access to compounded medications would be severely restricted;
  • The cost of your compounded medications would drastically increase;
  • The quality of compounded medications would suffer;
  • You and your practice would be burdened by additional FDA regulatory oversight;
  • And more.

Find out more about how the new guidance could impact you and your patients.